论文部分内容阅读
采用多肽类一般提取方法提取脾中的多肽制成脾肽胶囊．观察其治疗恶性肿瘤的临床辅助性疗效。选择临床62例肿瘤患者，随机分为对照组、保尔佳组和保尔佳加脾肽胶囊组（后2组为试验组）。以体重、食欲、疼痛、白细胞、红细胞、血红蛋白、血清总蛋白及健康状态等为指标进行测量和评价。结果：2试验组与对照组比较，各项指标差异有显著性（P＜0．05）；2试验组间比较差异无显著意义（P＞0．05）。提示脾肽在治疗恶性肿瘤方面具有一定的辅助性疗效。
The peptides were extracted from the spleen using peptide extraction methods to make spleen peptide capsules. Observe the clinical adjuvant effects of treating malignant tumors. Sixty-two patients with clinical tumors were randomly divided into control group, Paujia group and Baojiajia spleen peptide capsule group (the latter two groups were the experimental group). Measurements and evaluations were made on the basis of weight, appetite, pain, white blood cells, red blood cells, hemoglobin, serum total protein, and health status. RESULTS: There were significant differences in each index between the experimental group and the control group (P<0.05); 2 There was no significant difference between the experimental groups (P>0.05). It is suggested that spleen peptides have a certain adjuvant effect in the treatment of malignant tumors.